Puma Biotechnology | PBYI - Заемный капитал





Заемный капитал Изменить Дата
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Amgen USD 51.89B 1.88B 2026-03
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 20.86B 1.27B 2026-03
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Incyte USD 29.41M 785K 2026-03
MacroGenics USD 70M 256K 2025-12
Moderna USD 603M 7M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Takeda JPY 4.37T 99.51B 2026-03
TG Therapeutics USD 745.14M 499.5M 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12